251 related articles for article (PubMed ID: 21829212)
1. Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma.
Kabadi SV; Stoica BA; Byrnes KR; Hanscom M; Loane DJ; Faden AI
J Cereb Blood Flow Metab; 2012 Jan; 32(1):137-49. PubMed ID: 21829212
[TBL] [Abstract][Full Text] [Related]
2. CR8, a novel inhibitor of CDK, limits microglial activation, astrocytosis, neuronal loss, and neurologic dysfunction after experimental traumatic brain injury.
Kabadi SV; Stoica BA; Loane DJ; Luo T; Faden AI
J Cereb Blood Flow Metab; 2014 Mar; 34(3):502-13. PubMed ID: 24398934
[TBL] [Abstract][Full Text] [Related]
3. Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma.
Hilton GD; Stoica BA; Byrnes KR; Faden AI
J Cereb Blood Flow Metab; 2008 Nov; 28(11):1845-59. PubMed ID: 18612315
[TBL] [Abstract][Full Text] [Related]
4. CR8, a selective and potent CDK inhibitor, provides neuroprotection in experimental traumatic brain injury.
Kabadi SV; Stoica BA; Hanscom M; Loane DJ; Kharebava G; Murray Ii MG; Cabatbat RM; Faden AI
Neurotherapeutics; 2012 Apr; 9(2):405-21. PubMed ID: 22167461
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 gene ablation confers neuroprotection in traumatic brain injury.
Kabadi SV; Stoica BA; Loane DJ; Byrnes KR; Hanscom M; Cabatbat RM; Tan MT; Faden AI
J Neurotrauma; 2012 Mar; 29(5):813-27. PubMed ID: 21895533
[TBL] [Abstract][Full Text] [Related]
6. PARP-1 inhibition attenuates neuronal loss, microglia activation and neurological deficits after traumatic brain injury.
Stoica BA; Loane DJ; Zhao Z; Kabadi SV; Hanscom M; Byrnes KR; Faden AI
J Neurotrauma; 2014 Apr; 31(8):758-72. PubMed ID: 24476502
[TBL] [Abstract][Full Text] [Related]
7. Exogenous T3 administration provides neuroprotection in a murine model of traumatic brain injury.
Crupi R; Paterniti I; Campolo M; Di Paola R; Cuzzocrea S; Esposito E
Pharmacol Res; 2013 Apr; 70(1):80-9. PubMed ID: 23313345
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury.
Di Giovanni S; Movsesyan V; Ahmed F; Cernak I; Schinelli S; Stoica B; Faden AI
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8333-8. PubMed ID: 15923260
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of geranylgeranylacetone in experimental traumatic brain injury.
Zhao Z; Faden AI; Loane DJ; Lipinski MM; Sabirzhanov B; Stoica BA
J Cereb Blood Flow Metab; 2013 Dec; 33(12):1897-908. PubMed ID: 23942364
[TBL] [Abstract][Full Text] [Related]
10. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
[TBL] [Abstract][Full Text] [Related]
11. Novel mGluR5 positive allosteric modulator improves functional recovery, attenuates neurodegeneration, and alters microglial polarization after experimental traumatic brain injury.
Loane DJ; Stoica BA; Tchantchou F; Kumar A; Barrett JP; Akintola T; Xue F; Conn PJ; Faden AI
Neurotherapeutics; 2014 Oct; 11(4):857-69. PubMed ID: 25096154
[TBL] [Abstract][Full Text] [Related]
12. Intravenous administration of Honokiol provides neuroprotection and improves functional recovery after traumatic brain injury through cell cycle inhibition.
Wang H; Liao Z; Sun X; Shi Q; Huo G; Xie Y; Tang X; Zhi X; Tang Z
Neuropharmacology; 2014 Nov; 86():9-21. PubMed ID: 24973706
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle inhibition reduces inflammatory responses, neuronal loss, and cognitive deficits induced by hypobaria exposure following traumatic brain injury.
Skovira JW; Wu J; Matyas JJ; Kumar A; Hanscom M; Kabadi SV; Fang R; Faden AI
J Neuroinflammation; 2016 Dec; 13(1):299. PubMed ID: 27903275
[TBL] [Abstract][Full Text] [Related]
14. Comparing effects of CDK inhibition and E2F1/2 ablation on neuronal cell death pathways in vitro and after traumatic brain injury.
Aubrecht TG; Faden AI; Sabirzhanov B; Glaser EP; Roelofs BA; Polster BM; Makarevich O; Stoica BA
Cell Death Dis; 2018 Nov; 9(11):1121. PubMed ID: 30401820
[TBL] [Abstract][Full Text] [Related]
15. Methylene blue exerts a neuroprotective effect against traumatic brain injury by promoting autophagy and inhibiting microglial activation.
Zhao M; Liang F; Xu H; Yan W; Zhang J
Mol Med Rep; 2016 Jan; 13(1):13-20. PubMed ID: 26572258
[TBL] [Abstract][Full Text] [Related]
16. Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury.
Byrnes KR; Loane DJ; Stoica BA; Zhang J; Faden AI
J Neuroinflammation; 2012 Feb; 9():43. PubMed ID: 22373400
[TBL] [Abstract][Full Text] [Related]
17. Isolated spinal cord contusion in rats induces chronic brain neuroinflammation, neurodegeneration, and cognitive impairment. Involvement of cell cycle activation.
Wu J; Stoica BA; Luo T; Sabirzhanov B; Zhao Z; Guanciale K; Nayar SK; Foss CA; Pomper MG; Faden AI
Cell Cycle; 2014; 13(15):2446-58. PubMed ID: 25483194
[TBL] [Abstract][Full Text] [Related]
18. Combined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive neuroprotection in experimental traumatic brain injury.
Piao CS; Loane DJ; Stoica BA; Li S; Hanscom M; Cabatbat R; Blomgren K; Faden AI
Neurobiol Dis; 2012 Jun; 46(3):745-58. PubMed ID: 22426396
[TBL] [Abstract][Full Text] [Related]
19. Administration of DHA Reduces Endoplasmic Reticulum Stress-Associated Inflammation and Alters Microglial or Macrophage Activation in Traumatic Brain Injury.
Harvey LD; Yin Y; Attarwala IY; Begum G; Deng J; Yan HQ; Dixon CE; Sun D
ASN Neuro; 2015; 7(6):. PubMed ID: 26685193
[TBL] [Abstract][Full Text] [Related]
20. Propofol limits microglial activation after experimental brain trauma through inhibition of nicotinamide adenine dinucleotide phosphate oxidase.
Luo T; Wu J; Kabadi SV; Sabirzhanov B; Guanciale K; Hanscom M; Faden J; Cardiff K; Bengson CJ; Faden AI
Anesthesiology; 2013 Dec; 119(6):1370-88. PubMed ID: 24121215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
